Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 04 02 2022
revised: 23 02 2022
accepted: 26 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Cytokine and chemokine receptors can promote tumor progression, invasion, and metastasis development by inducing different intracellular signaling pathways. The aim of this study was to determine the cytokine and chemokine receptor gene expression patterns in human melanoma cell lines. We found a large set of cytokine and chemokine receptor genes that were significantly differentially expressed between melanoma cell lines that originated from different subtypes of primary melanomas as well as cell lines that originated from melanoma metastases. The relative expressions of two receptor genes (

Identifiants

pubmed: 35269787
pii: ijms23052644
doi: 10.3390/ijms23052644
pmc: PMC8910570
pii:
doi:

Substances chimiques

Cytokines 0
Receptors, Chemokine 0
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Development and Innovation Fund d
ID : K-135752
Organisme : European Regional Development Fund
ID : GINOP-2.3.2-15-2016-00005
Organisme : Hungarian Academy of Sciences
ID : MTA11010 and TK2016-78
Organisme : New National Excellence Program of the Ministry for Innovation and Technology from the Source of National research, Development and Innovation Fund
ID : : UNKP-21-4-II-DE-361 and UNKP-21-4-II-DE-363

Références

Pharmacol Ther. 2010 Jul;127(1):1-8
pubmed: 20451553
J Control Release. 2021 Jan 10;329:614-623
pubmed: 33011241
Pigment Cell Melanoma Res. 2013 Jan;26(1):39-57
pubmed: 23095214
Annu Rev Immunol. 2009;27:29-60
pubmed: 18817510
J Leukoc Biol. 2006 Apr;79(4):639-51
pubmed: 16478915
Int J Hematol. 2001 Jul;74(1):3-8
pubmed: 11530802
Cancers (Basel). 2020 Feb 19;12(2):
pubmed: 32092958
Eur J Cancer. 2017 Sep;83:247-257
pubmed: 28756137
Expert Rev Clin Pharmacol. 2019 Mar;12(3):259-266
pubmed: 30652516
J Natl Cancer Inst. 2019 Feb 1;111(2):180-188
pubmed: 29912415
Trends Cancer. 2015 Sep;1(1):76-91
pubmed: 28741564
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1129-1138
pubmed: 31879345
Oncotarget. 2017 Feb 28;8(9):14428-14442
pubmed: 28129639
J Cancer Res Clin Oncol. 1989;115(6):554-7
pubmed: 2606930
Melanoma Res. 2012 Feb;22(1):1-8
pubmed: 22108608
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
J Exp Clin Cancer Res. 2018 Apr 27;37(1):92
pubmed: 29703238
Cancer Lett. 2007 Oct 28;256(2):137-65
pubmed: 17629396
Cancer Immunol Res. 2018 Mar;6(3):267-275
pubmed: 29362221
Int J Mol Sci. 2020 Nov 09;21(21):
pubmed: 33182504
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
Cancer. 2008 Dec 15;113(12):3341-8
pubmed: 18988292
Curr Probl Surg. 2013 Aug;50(8):351-82
pubmed: 23849560
Nucleic Acids Res. 2016 Jul 8;44(W1):W147-53
pubmed: 27190236
Cancer Metastasis Rev. 2018 Sep;37(2-3):245-255
pubmed: 29808460
Sci Rep. 2021 May 27;11(1):11221
pubmed: 34045496
Int J Oncol. 2018 Apr;52(4):1071-1080
pubmed: 29532857
Mol Cancer Ther. 2019 Feb;18(2):289-300
pubmed: 30482853
Protein Cell. 2012 Aug;3(8):571-80
pubmed: 22684736
Cancers (Basel). 2020 Jan 24;12(2):
pubmed: 31991604
Nat Rev Cancer. 2004 Jan;4(1):11-22
pubmed: 14708024
Annu Rev Immunol. 2015;33:139-67
pubmed: 25493332
J Immunoassay Immunochem. 2015;36(6):559-66
pubmed: 25839711
J Dermatol Sci. 2004 Nov;36(2):71-8
pubmed: 15519136
Mol Cancer Ther. 2017 Feb;16(2):312-322
pubmed: 27980102
Front Immunol. 2018 Oct 29;9:2480
pubmed: 30420855
Biochim Biophys Acta. 2016 Apr;1863(4):770-84
pubmed: 26844774
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
Arch Dermatol. 2006 Dec;142(12):1551-8
pubmed: 17178980
Clin Epidemiol. 2016 May 26;8:109-22
pubmed: 27307765
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):149-56
pubmed: 12520385
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
J Cancer. 2019 Aug 7;10(19):4574-4587
pubmed: 31528221
Nature. 2017 May 3;545(7652):116
pubmed: 28470201
Hematol Oncol Clin North Am. 2009 Jun;23(3):501-13, ix
pubmed: 19464599
Nat Commun. 2015 Apr 09;6:6683
pubmed: 25865119
J Clin Oncol. 2018 Mar 1;36(7):667-673
pubmed: 28991513
Mol Pharm. 2018 Sep 4;15(9):3642-3653
pubmed: 29337566
Exp Dermatol. 2020 Jan;29(1):39-50
pubmed: 31602702
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Oncol Lett. 2017 Oct;14(4):4106-4114
pubmed: 28943917
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905

Auteurs

Viktoria Koroknai (V)

MTA-DE Public Health Research Group, University of Debrecen, 4032 Debrecen, Hungary.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

István Szász (I)

MTA-DE Public Health Research Group, University of Debrecen, 4032 Debrecen, Hungary.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Krisztina Jámbor (K)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Doctoral School of Health Sciences, University of Debrecen, 4032 Debrecen, Hungary.

Margit Balázs (M)

MTA-DE Public Health Research Group, University of Debrecen, 4032 Debrecen, Hungary.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH